gip and glp 1 receptors New strategies for the treatment of obesity metabolic dysfunctions TrimRX | GLP-1 vs GIP:
Description
BMJ open
doi 10.1093/ibd/izae250 101 GorelikYGhersinILujanRShlonDLoewenberg WeisbandYBen-TovAet al
In individuals with AD, GLP-1RAs did not exert disease-modifying effects on cognition
Novel small molecule glucagon-like peptide-1 agonist stimulates insulin secretion in rodents and from human islets
